Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging AI and machine learning for oncology drug discovery, has announced it will report its Q2 2024 financial results on Wednesday, August 14, 2024, before market open. The company will host a corporate update conference call and live audio webcast at 8:30 a.m. ET on the same day.
Investors can access the call via toll-free (877-407-3982) or international (201-493-6780) numbers, using Conference ID 13748154. A live webcast will also be available on the company's investor relations website.
Predictive Oncology Inc. (NASDAQ: POAI), un'azienda orientata alla scienza che sfrutta l'IA e il machine learning per la scoperta di farmaci in oncologia, ha annunciato che riferir脿 i suoi risultati finanziari del Q2 2024 尘别谤肠辞濒别诲矛 14 agosto 2024, prima dell'apertura del mercato. L'azienda ospiter脿 una call di aggiornamento aziendale e una diretta audio via web alle 8:30 a.m. ET nello stesso giorno.
Gli investitori possono accedere alla chiamata tramite il numero verde (877-407-3982) o il numero internazionale (201-493-6780), utilizzando l'ID Conferenza 13748154. Sar脿 inoltre disponibile una diretta web sul sito delle relazioni con gli investitori dell'azienda.
Predictive Oncology Inc. (NASDAQ: POAI), una empresa impulsada por la ciencia que utiliza IA y aprendizaje autom谩tico para el descubrimiento de f谩rmacos oncol贸gicos, ha anunciado que informar谩 sobre sus resultados financieros del Q2 2024 el mi茅rcoles 14 de agosto de 2024, antes de la apertura del mercado. La compa帽铆a llevar谩 a cabo una conferencia telef贸nica de actualizaci贸n corporativa y una transmisi贸n de audio en vivo a las 8:30 a.m. ET el mismo d铆a.
Los inversores pueden acceder a la llamada a trav茅s del n煤mero gratuito (877-407-3982) o del n煤mero internacional (201-493-6780), utilizando el ID de Conferencia 13748154. Tambi茅n estar谩 disponible una transmisi贸n en vivo en el sitio web de relaciones con inversores de la empresa.
Predictive Oncology Inc. (NASDAQ: POAI)電� AI 氚� 毹胳嫚 霟嫕鞚� 頇滌毄頃橃棳 膦呾枒頃� 鞎诫 氚滉铂鞚� 歆勴枆頃橂姅 瓿柬暀 欷戩嫭 旮办梾鞙茧, 2024雲� 2攵勱赴 鞛 瓴瓣臣毳� 2024雲� 8鞗� 14鞚� 靾橃殧鞚� 鞁滌灔 臧滌灔 鞝勳棎 氚滍憸頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 臧欖潃 雮� 氙戈淡 霃欕秬 響滌鞁� 旮办 鞓れ爠 8鞁� 30攵�鞐� 旮办梾 鞐呺嵃鞚错姼 鞝勴檾 須岇潣 氚� 霛检澊敫� 鞓る敂鞓� 鞗轨簮鞀ろ姼毳� 臧滌禍頃╇媹雼�.
韴瀽鞛愲姅 氍措 鞝勴檾氩堩樃 (877-407-3982) 霕愲姅 甑牅 鞝勴檾氩堩樃 (201-493-6780)毳� 韱淀暣 鞝勴檾毳� 氚涭潉 靾� 鞛堨溂氅�, 須岇潣 ID 13748154毳� 靷毄頃挫暭 頃╇媹雼�. 須岇偓鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐愳劀霃� 霛检澊敫� 鞗轨簮鞀ろ姼臧� 鞝滉车霅╇媹雼�.
Predictive Oncology Inc. (NASDAQ: POAI), une entreprise ax茅e sur la science qui utilise l'IA et l'apprentissage automatique pour la d茅couverte de m茅dicaments en oncologie, a annonc茅 qu'elle publiera ses r茅sultats financiers du T2 2024 le mercredi 14 ao没t 2024, avant l'ouverture des march茅s. L'entreprise organisera un appel de mise 脿 jour d'entreprise et un webinaire audio en direct 脿 8h30, heure de l'Est le m锚me jour.
Les investisseurs peuvent acc茅der 脿 l'appel via le num茅ro sans frais (877-407-3982) ou le num茅ro international (201-493-6780), en utilisant l'ID de conf茅rence 13748154. Un webinaire en direct sera 茅galement disponible sur le site internet des relations investisseurs de l'entreprise.
Predictive Oncology Inc. (NASDAQ: POAI), ein wissenschaftlich orientiertes Unternehmen, das KI und maschinelles Lernen f眉r die Entdeckung von Onkologika nutzt, hat angek眉ndigt, dass es am Mittwoch, den 14. August 2024, vor der Markter枚ffnung seine finanziellen Ergebnisse f眉r das 2. Quartal 2024 berichten wird. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz zur Unternehmensaktualisierung und eine Live-Audio-Webcast anbieten.
Investoren k枚nnen die Konferenz 眉ber die geb眉hrenfreie Nummer (877-407-3982) oder die internationale Nummer (201-493-6780) erreichen, indem sie die Konferenz-ID 13748154 verwenden. Ein Live-Webcast wird auch auf der Investor-Relations-Website des Unternehmens zur Verf眉gung stehen.
- None.
- None.
Management to host conference call and webcast at 8:30am ET
PITTSBURGH, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc.聽(NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced that it will report its financial results for the second quarter ended June 30, 2024 before the markets open on Wednesday, August 14, 2024. The company will host a corporate update conference call and live audio webcast at 8:30 a.m. ET.
| Live Conference Call & Webcast: | |
| Toll Free:聽 | 877-407-3982 |
| 滨苍迟别谤苍补迟颈辞苍补濒:听听 | 201-493-6780 |
| Conference ID:聽 | 13748154 |
| Call me鈩�: | |
A live webcast will be available or in the Investors section of the Predictive Oncology website at .
About Predictive Oncology
Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company鈥檚 scientifically validated AI platform, PEDAL, is able to predict with
Contact:
Predictive Oncology Investor Relations
Tim McCarthy听听
LifeSci Advisors, LLC.听听
听听
Forward-Looking Statements:
Certain matters discussed in this release contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties and assumptions about our operations and the investments we make. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, changes in management, plans and objectives of management are forward-looking statements. The words 鈥渁nticipate,鈥� 鈥渂elieve,鈥� 鈥渆stimate,鈥� 鈥渆xpect,鈥� 鈥渋ntend,鈥� 鈥渕ay,鈥� 鈥減lan,鈥� 鈥渨ould,鈥� 鈥渢arget鈥� and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors including, among other things, factors discussed under the heading 鈥淩isk Factors鈥� in our filings with the聽SEC. Except as expressly required by law, the Company disclaims any intent or obligation to update these forward-looking statements.
FAQ
When will Predictive Oncology (POAI) report its Q2 2024 financial results?
What time is Predictive Oncology's (POAI) Q2 2024 earnings conference call?
How can investors access Predictive Oncology's (POAI) Q2 2024 earnings call?
